VIR peer analysis
Vir Biotechnology (VIR) against its competitors: price, today's move, 1-year return and market value side by side.
VIR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABUS Arbutus Biopharma | $4.01 | -4.75% | -17.15% | $834.03M |
| ASMB Assembly Biosciences | $20.13 | -3.50% | -33.17% | $409.86M |
| AVIR Atea Pharmaceuticals | $4.10 | -0.24% | 25.38% | – |
| BCRX BioCryst | $8.24 | -2.66% | 13.72% | $2.16B |
| BNTX BioNTech | $87.49 | -0.77% | -16.41% | $22.15B |
| COCP Cocrystal Pharma | $0.99 | 1.53% | -7.01% | $19.17M |
| ENTA Enanta Pharmaceuticals | $10.71 | -3.95% | -1.38% | $311.93M |
| MRNA Moderna | $220.50 | -0.55% | 683.58% | $88.52B |
| NVAX Novavax | $9.54 | -5.36% | 13.17% | $1.66B |
| VALN Valneva | $5.45 | -4.55% | -40.24% | – |
| VIR Vir Biotechnology | $11.02 | -2.48% | 85.83% | $1.91B |
- VIR's peers: ABUS (Arbutus Biopharma), ASMB (Assembly Biosciences), AVIR (Atea Pharmaceuticals), BCRX (BioCryst), BNTX (BioNTech), COCP (Cocrystal Pharma), ENTA (Enanta Pharmaceuticals), MRNA (Moderna).
Updated 2026-11-03 11:33 UTC